| Dr Mark H Kalenian, MD | |
|
520 John D. Odom Rd., Dothan, AL 36303-9461 | |
| (334) 794-2718 | |
| (334) 671-1905 |
| Full Name | Dr Mark H Kalenian |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 39 Years |
| Location | 520 John D. Odom Rd., Dothan, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972504397 | NPI | - | NPPES |
| 051509093 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | AL16176 (Alabama) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alabama Asthma And Allergy, Pc | 9537155882 | 2 |
| Continuum Health Aic, Inc | 0143626382 | 3 |
News Archive
Graduate students Mingde 'Jack' Zheng and Joseph Sherba have developed a novel, microfluidic platform for monitoring electroporation and molecular delivery at the single cell-level as part of a collaborative re-search team led by Professors Jeffrey Zahn and David Shreiber in the Department of Biomedical Engineer-ing and Professors Hao Lin and Jerry Shan in the Department of Mechanical and Aerospace Engineering at Rutgers,
The Perelman School of Medicine at the University of Pennsylvania has been awarded more than $1 million by the U.S. Centers for Disease Control and Prevention (CDC) to develop new approaches to combat antibiotic resistance.
Researchers who investigated the connection between chronic cerebrospinal venous insufficiency (a reported condition characterized as a blockage in the veins that drain blood from the brain and spinal cord and returns it to the heart) and multiple sclerosis indicate that a minimally invasive endovascular treatment for CCSVI, is safe and may produce "significant," short-term improvement in physical- and mental health-related quality of life in individuals with MS.
People with diabetes are at increased risk of developing a severe course of COVID-19 compared to people without diabetes.
› Verified 3 days ago
| Entity Name | Alabama Asthma & Allergy, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023170461 PECOS PAC ID: 9537155882 Enrollment ID: O20050509000661 |
News Archive
Graduate students Mingde 'Jack' Zheng and Joseph Sherba have developed a novel, microfluidic platform for monitoring electroporation and molecular delivery at the single cell-level as part of a collaborative re-search team led by Professors Jeffrey Zahn and David Shreiber in the Department of Biomedical Engineer-ing and Professors Hao Lin and Jerry Shan in the Department of Mechanical and Aerospace Engineering at Rutgers,
The Perelman School of Medicine at the University of Pennsylvania has been awarded more than $1 million by the U.S. Centers for Disease Control and Prevention (CDC) to develop new approaches to combat antibiotic resistance.
Researchers who investigated the connection between chronic cerebrospinal venous insufficiency (a reported condition characterized as a blockage in the veins that drain blood from the brain and spinal cord and returns it to the heart) and multiple sclerosis indicate that a minimally invasive endovascular treatment for CCSVI, is safe and may produce "significant," short-term improvement in physical- and mental health-related quality of life in individuals with MS.
People with diabetes are at increased risk of developing a severe course of COVID-19 compared to people without diabetes.
› Verified 3 days ago
| Entity Name | Alabama Allergy And Asthma Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780629535 PECOS PAC ID: 1254358310 Enrollment ID: O20051027000853 |
News Archive
Graduate students Mingde 'Jack' Zheng and Joseph Sherba have developed a novel, microfluidic platform for monitoring electroporation and molecular delivery at the single cell-level as part of a collaborative re-search team led by Professors Jeffrey Zahn and David Shreiber in the Department of Biomedical Engineer-ing and Professors Hao Lin and Jerry Shan in the Department of Mechanical and Aerospace Engineering at Rutgers,
The Perelman School of Medicine at the University of Pennsylvania has been awarded more than $1 million by the U.S. Centers for Disease Control and Prevention (CDC) to develop new approaches to combat antibiotic resistance.
Researchers who investigated the connection between chronic cerebrospinal venous insufficiency (a reported condition characterized as a blockage in the veins that drain blood from the brain and spinal cord and returns it to the heart) and multiple sclerosis indicate that a minimally invasive endovascular treatment for CCSVI, is safe and may produce "significant," short-term improvement in physical- and mental health-related quality of life in individuals with MS.
People with diabetes are at increased risk of developing a severe course of COVID-19 compared to people without diabetes.
› Verified 3 days ago
| Entity Name | Continuum Health Aic, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669129169 PECOS PAC ID: 0143626382 Enrollment ID: O20220426002625 |
News Archive
Graduate students Mingde 'Jack' Zheng and Joseph Sherba have developed a novel, microfluidic platform for monitoring electroporation and molecular delivery at the single cell-level as part of a collaborative re-search team led by Professors Jeffrey Zahn and David Shreiber in the Department of Biomedical Engineer-ing and Professors Hao Lin and Jerry Shan in the Department of Mechanical and Aerospace Engineering at Rutgers,
The Perelman School of Medicine at the University of Pennsylvania has been awarded more than $1 million by the U.S. Centers for Disease Control and Prevention (CDC) to develop new approaches to combat antibiotic resistance.
Researchers who investigated the connection between chronic cerebrospinal venous insufficiency (a reported condition characterized as a blockage in the veins that drain blood from the brain and spinal cord and returns it to the heart) and multiple sclerosis indicate that a minimally invasive endovascular treatment for CCSVI, is safe and may produce "significant," short-term improvement in physical- and mental health-related quality of life in individuals with MS.
People with diabetes are at increased risk of developing a severe course of COVID-19 compared to people without diabetes.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark H Kalenian, MD 520 John D. Odom Rd., Dothan, AL 36303-9461 Ph: (334) 794-2718 | Dr Mark H Kalenian, MD 520 John D. Odom Rd., Dothan, AL 36303-9461 Ph: (334) 794-2718 |
News Archive
Graduate students Mingde 'Jack' Zheng and Joseph Sherba have developed a novel, microfluidic platform for monitoring electroporation and molecular delivery at the single cell-level as part of a collaborative re-search team led by Professors Jeffrey Zahn and David Shreiber in the Department of Biomedical Engineer-ing and Professors Hao Lin and Jerry Shan in the Department of Mechanical and Aerospace Engineering at Rutgers,
The Perelman School of Medicine at the University of Pennsylvania has been awarded more than $1 million by the U.S. Centers for Disease Control and Prevention (CDC) to develop new approaches to combat antibiotic resistance.
Researchers who investigated the connection between chronic cerebrospinal venous insufficiency (a reported condition characterized as a blockage in the veins that drain blood from the brain and spinal cord and returns it to the heart) and multiple sclerosis indicate that a minimally invasive endovascular treatment for CCSVI, is safe and may produce "significant," short-term improvement in physical- and mental health-related quality of life in individuals with MS.
People with diabetes are at increased risk of developing a severe course of COVID-19 compared to people without diabetes.
› Verified 3 days ago